Related Experiment Video
Updated: Dec 15, 2025

10:41
Detection of Toxin Translocation into the Host Cytosol by Surface Plasmon Resonance
Published on: January 3, 2012
13.6K
Structure-Activity Relationship Studies of Retro-1 Analogues against Shiga Toxin
Hajer Abdelkafi1, Aurélien Michau2, Valérie Pons1
1Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SCBM, 91191 Gif-sur-Yvette, France.
Journal of Medicinal Chemistry
|July 11, 2020
Summary
Retro-1 blocks toxin entry into cells by disrupting intracellular transport. A structure-activity relationship study improved Retro-1's efficacy against Shiga toxin by 70-fold, offering a promising therapeutic lead.
Area of Science:
- Biochemistry
- Cell Biology
- Toxicology
Background:
- Ricin and Shiga toxins pose significant health threats.
- Intracellular trafficking is crucial for toxin activity.
- Retro-1 identified as an inhibitor of retrograde transport.
Purpose of the Study:
- To enhance the inhibitory activity of Retro-1 against ricin and Shiga toxins.
- To optimize Retro-1 through structure-activity relationship (SAR) studies.
- To develop improved therapeutics against toxin-induced cytotoxicity.
Main Methods:
- High-throughput screening to identify Retro-1.
- Structure-activity relationship (SAR) study to design analogues.
- Cell-based assays measuring cytotoxicity and protein synthesis inhibition.
- Quantification of half-maximal effective concentration (EC50) for Shiga toxin.
Main Results:
- Retro-1 inhibits ricin and Shiga toxins by blocking retrograde transport from endosomes to the Golgi.
- SAR study identified a Retro-1 analogue with significantly improved potency.
- The optimized analogue demonstrated a 70-fold lower EC50 against Shiga toxin cytotoxicity.
- Enhanced inhibition of Shiga toxin-induced cell protein synthesis disruption.
Conclusions:
- Optimized Retro-1 analogues represent a promising strategy for neutralizing ricin and Shiga toxins.
- Targeting intracellular trafficking pathways offers a novel therapeutic approach.
- Further development of Retro-1 analogues could lead to effective antitoxin agents.
More Related Videos
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
813
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
813
Structure-Activity Relationships and Drug Design
1.5K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.5K

